A four-year-old girl who had spent months in pain at the Ho Teaching Hospital has been given a second chance at life after the Ghana Medical Trust Fund, operating under the MahamaCares initiative, absorbed the full cost of her cancer treatment.
The child, Elsa Klabi, hails from Kpando in the Volta Region and was diagnosed with Wilms’ Tumour, a childhood kidney cancer characterised by a large intra-abdominal mass. For nearly six months, she remained on admission at the hospital’s Paediatric Oncology Unit as her condition worsened, largely due to her family’s inability to finance the surgery and associated treatment required to save her life.
That financial barrier was finally broken when MahamaCares approved a total of GH¢46,000 to cover chemotherapy, surgery, and supportive care—clearing the way for doctors to proceed with the long-delayed operation.
Medical staff at the Ho Teaching Hospital confirmed that Elsa’s treatment plan had stalled solely because of cost. According to Paediatric Oncologist Dr Kokou Amegan-Aho, the intervention from MahamaCares removed the last obstacle preventing the surgical team from acting decisively.
Behind the scenes, the breakthrough followed a desperate public appeal by Elsa’s mother, Ms Esther Addeh, a petty trader, who had taken to social media in search of help. Her plea caught the attention of the Volta Regional Minister, Hon. James Gunu, whose engagement with the hospital’s management—including Chief Executive Officer Dr Hintermann K. K. Mbroh—set in motion the processes that culminated in MahamaCares assuming full responsibility for the medical bill.
When news of the approval reached the ward, emotions ran high. Ms Addeh was overwhelmed with relief, breaking down in tears as the weight of uncertainty that had hung over her daughter’s future was finally lifted.
“This support has saved my daughter’s life. I am deeply grateful to the Government and everyone behind MahamaCares,” she said.
Hospital authorities have since praised the MahamaCares initiative, describing it as a critical intervention for patients who require specialised and high-cost care but lack the financial means to access it.
Beyond Elsa’s case, the development has been cited as a clear demonstration of how targeted public health financing can bridge the gap between medical expertise and patient survival—particularly for vulnerable children whose lives depend not on diagnosis alone, but on timely access to care.




